Peter M Tessier (Peter Tessier)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Topics

Monoclonal Antibody

Infectious Diseases

Machine Learning

Top Venues

bioRxiv : the preprint server for biology

Molecular pharmaceutics

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

John S Schardt, Neelan S Sivaneri, Peter M Tessier
Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Anna Kopp, Shujun Dong, Hyeyoung Kwon, Tiexin Wang, Alec A Desai, Jennifer J Linderman, Peter M Tessier, Greg M Thurber
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies. bioRxiv : the preprint server for biology (2024)
Anna Kopp, Shujun Dong, Hyeyoung Kwon, Tiexin Wang, Alec A Desai, Jennifer J Linderman, Peter M Tessier, Greg M Thurber
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies. bioRxiv : the preprint server for biology (2024)
Emily K Makowski, Hsin-Ting Chen, Tiexin Wang, Lina Wu, Jie Huang, Marissa Mock, Patrick Underhill, Emma Pelegri-O'Day, Erick Maglalang, Dwight Winters, Peter M Tessier
Reduction of monoclonal antibody viscosity using interpretable machine learning. mAbs 16 (1) (2024)
Emily K Makowski, Hsin-Ting Chen, Tiexin Wang, Lina Wu, Jie Huang, Marissa Mock, Patrick Underhill, Emma Pelegri-O'Day, Erick Maglalang, Dwight Winters, Peter M Tessier
Reduction of monoclonal antibody viscosity using interpretable machine learning. mAbs 16 (1) (2024)
Emily K Makowski, Hsin-Ting Chen, Tiexin Wang, Lina Wu, Jie Huang, Marissa Mock, Patrick Underhill, Emma Pelegri-O'Day, Erick Maglalang, Dwight Winters, Peter M Tessier
Reduction of monoclonal antibody viscosity using interpretable machine learning. mAbs 16 (1) (2024)
Emily K Makowski, Hsin-Ting Chen, Tiexin Wang, Lina Wu, Jie Huang, Marissa Mock, Patrick Underhill, Emma Pelegri-O'Day, Erick Maglalang, Dwight Winters, Peter M Tessier
Reduction of monoclonal antibody viscosity using interpretable machine learning. mAbs 16 (1) (2024)
John S Schardt, Neelan S Sivaneri, Peter M Tessier
Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
John S Schardt, Neelan S Sivaneri, Peter M Tessier
Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Anna Kopp, Shujun Dong, Hyeyoung Kwon, Tiexin Wang, Alec A Desai, Jennifer J Linderman, Peter M Tessier, Greg M Thurber
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies. bioRxiv : the preprint server for biology (2024)
Ariel Tennenhouse, Lev Khmelnitsky, Razi Khalaila, Noa Yeshaya, Ashish Noronha, Moshit Lindzen, Emily K Makowski, Ira Zaretsky, Yael Fridmann Sirkis, Yael Galon-Wolfenson, Peter M Tessier, Jakub Abramson, Yosef Yarden, Deborah Fass, Sarel Jacob Fleishman
Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nature biomedical engineering (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Harkamal S Jhajj, John S Schardt, Namir Khalasawi, Emily L Yao, Timon S Lwo, Na-Young Kwon, Ryen L O'Meara, Alec A Desai, Peter M Tessier
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. bioRxiv : the preprint server for biology (2023)
Harkamal S Jhajj, John S Schardt, Namir Khalasawi, Emily L Yao, Timon S Lwo, Na-Young Kwon, Ryen L O'Meara, Alec A Desai, Peter M Tessier
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. bioRxiv : the preprint server for biology (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Harkamal S Jhajj, John S Schardt, Namir Khalasawi, Emily L Yao, Timon S Lwo, Na-Young Kwon, Ryen L O'Meara, Alec A Desai, Peter M Tessier
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. bioRxiv : the preprint server for biology (2023)
Ryan Limbocker, Nunilo Cremades, Roberta Cascella, Peter M Tessier, Christopher M Dobson, Fabrizio Chiti
Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases. Accounts of chemical research (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Ghasidit Pornnoppadol, Layne G Bond, Michael J Lucas, Jennifer M Zupancic, Yun-Huai Kuo, Boya Zhang, Colin F Greineder, Peter M Tessier
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs. bioRxiv : the preprint server for biology (2023)
Matthew D Smith, Marshall A Case, Emily K Makowski, Peter M Tessier
Position-Specific Enrichment Ratio Matrix scores predict antibody variant properties from deep sequencing data. bioRxiv : the preprint server for biology (2023)
Alec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, Julia E Gerson, Kelly N DuBois, Mary E Skinner, Lisa M Sharkey, Nikki McArthur, Sean P Ferris, Nemil N Bhatt, Emily K Makowski, Matthew D Smith, Hongwei Chen, Jie Huang, Cynthia Jerez, Ravi S Kane, Nicholas M Kanaan, Henry L Paulson, Peter M Tessier
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. bioRxiv : the preprint server for biology (2023)
Harkamal S Jhajj, John S Schardt, Namir Khalasawi, Emily L Yao, Timon S Lwo, Na-Young Kwon, Ryen L O'Meara, Alec A Desai, Peter M Tessier
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. bioRxiv : the preprint server for biology (2023)
Harkamal S Jhajj, John S Schardt, Namir Khalasawi, Emily L Yao, Timon S Lwo, Na-Young Kwon, Ryen L O'Meara, Alec A Desai, Peter M Tessier
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. bioRxiv : the preprint server for biology (2023)
Ghasidit Pornnoppadol, Layne G Bond, Michael J Lucas, Jennifer M Zupancic, Yun-Huai Kuo, Boya Zhang, Colin F Greineder, Peter M Tessier
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs. bioRxiv : the preprint server for biology (2023)
Monica L I Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Rude Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Emily K Makowski, Tiexin Wang, Jennifer M Zupancic, Jie Huang, Lina Wu, John S Schardt, Anne S De Groot, Stephanie L Elkins, William D Martin, Peter M Tessier
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nature biomedical engineering (2023)
Harkamal S Jhajj, John S Schardt, Namir Khalasawi, Emily L Yao, Timon S Lwo, Na-Young Kwon, Ryen L O'Meara, Alec A Desai, Peter M Tessier
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. bioRxiv : the preprint server for biology (2023)
Emily K Makowski, Lina Wu, Alec A Desai, Peter M Tessier
Highly sensitive detection of antibody nonspecific interactions using flow cytometry. mAbs 13 (1) (2022)
Weishu Wu, Xiaotian Tan, Jennifer Zupancic, John S Schardt, Alec A Desai, Matthew D Smith, Jie Zhang, Liangzhi Xie, Maung Khaing Oo, Peter M Tessier, Xudong Fan
Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies. Analytical chemistry 94 (10) (2022)
Emily K Makowski, Hongwei Chen, Matthew Lambert, Eric M Bennett, Nicole S Eschmann, Yulei Zhang, Jennifer M Zupancic, Alec A Desai, Matthew D Smith, Wenjia Lou, Amendra Fernando, Timothy Tully, Christopher J Gallo, Laura Lin, Peter M Tessier
Reduction of therapeutic antibody self-association using yeast-display selections and machine learning. mAbs 14 (1) (2022)
Emily K Makowski, Lina Wu, Priyanka Gupta, Peter M Tessier
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. mAbs 13 (1) (2022)
Emily K Makowski, Patrick C Kinnunen, Jie Huang, Lina Wu, Matthew D Smith, Tiexin Wang, Alec A Desai, Craig N Streu, Yulei Zhang, Jennifer M Zupancic, John S Schardt, Jennifer J Linderman, Peter M Tessier
Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space. Nature communications 13 (1) (2022)
Priyanka Gupta, Emily K Makowski, Sandeep Kumar, Yulei Zhang, Justin M Scheer, Peter M Tessier
Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties. Molecular pharmaceutics 19 (3) (2022)
Charles G Starr, Emily K Makowski, Lina Wu, Brendan Berg, Jonathan S Kingsbury, Yatin R Gokarn, Peter M Tessier
Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties. Molecular pharmaceutics 18 (7) (2021)
Jennifer M Zupancic, John S Schardt, Alec A Desai, Emily K Makowski, Matthew D Smith, Ghasidit Pornnoppadol, Mayara Garcia de Mattos Barbosa, Marilia Cascalho, Thomas M Lanigan, Peter M Tessier
Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants. Advanced therapeutics 4 (8) (2021)
Wenjia Lou, Samuel D Stimple, Alec A Desai, Emily K Makowski, Sibel Kalyoncu, Jesper E Mogensen, Lotte T Spang, Désirée J Asgreen, Arne Staby, Karen Duus, Jan Amstrup, Yulei Zhang, Peter M Tessier
Directed evolution of conformation-specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations. Biotechnology and bioengineering 118 (2) (2020)
Yulei Zhang, Lina Wu, Priyanka Gupta, Alec A Desai, Matthew D Smith, Lilia A Rabia, Seth D Ludwig, Peter M Tessier
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity. Molecular pharmaceutics 17 (7) (2020)
Magfur E Alam, Gregory V Barnett, Thomas R Slaney, Charles G Starr, Tapan K Das, Peter M Tessier
Deamidation Can Compromise Antibody Colloidal Stability and Enhance Aggregation in a pH-Dependent Manner. Molecular pharmaceutics 16 (5) (2019)
Samuel D Stimple, Sibel Kalyoncu, Alec A Desai, Jesper E Mogensen, Lotte T Spang, Désirée J Asgreen, Arne Staby, Peter M Tessier
Sensitive detection of glucagon aggregation using amyloid fibril-specific antibodies. Biotechnology and bioengineering 116 (8) (2019)
Samuel D Stimple, Matthew D Smith, Peter M Tessier
Directed evolution methods for overcoming trade-offs between protein activity and stability. AIChE journal. American Institute of Chemical Engineers 66 (3) (2019)
Magfur E Alam, Steven B Geng, Christian Bender, Seth D Ludwig, Lars Linden, Rene Hoet, Peter M Tessier
Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability. Molecular pharmaceutics 15 (1) (2017)